Kiyoshi Takayama (President, NBHL) will have a poster presentation at Antibody Engineering & Therapeutics Asia 2020 to be held in The Westin Miyako Kyoto, Japan, from February 24th to 26th, 2020. Our presentation will focus on the new MoGRAA^® discovery engine powered by the innovative high-throughput single-cell technology RiGRASS^TM for discovering functional anti-GPCR antibodies. Please stop by our poster, and we look forward to meeting you to discuss future collaboration opportunities.

[URL]

https://informaconnect.com/antibody-engineering-therapeutics-asia/

NBHL will be at the BIO CEO & Investor Conference 2020 to be held in New York from February 10th to 11th, 2020. NBHL’s Business Development team will attend this exciting event. We are looking forward to meeting you in New York to discuss future opportunities.

For more information on this event, please visit https://www.bio.org/events/bio-ceo-investor-conference